Clinical Trial Update: Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the safety, tolerability, and exploratory efficacy of the investigational compound PBT2 in patients with early Alzheimer's disease has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PBT2

Snippet

Sponsor: Prana Biotechnology Limited | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED